Compare Cytokinetics Inc (CYTK) vs Jabil Inc (JBL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Jabil Inc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Jabil Inc trades at $360.5 (market cap $37.37B). The key difference: Jabil Inc is far larger — about 3.5× Cytokinetics Inc's market cap, and Jabil Inc pays a 0.09% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | JBL | |
|---|---|---|
Market Cap | $10.63B | $37.37B |
Sector | Technology | Technology |
52-Week High | $87.26 | $385.50 |
52-Week Low | $34.31 | $192.49 |
Enterprise Value | $10.74B | $39.90B |
Dividend Yield | — | 0.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Jabil Inc
Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →
